Vertex Pharmaceuticals, Inc.

Company overview

Vertex Pharmaceuticals (Vertex) is a global biotechnology company engaged in discovering, developing and commercializing small molecule drugs for the treatment of major diseases like viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain. The company primarily operates in the US. It is headquartered in Cambridge, Massachusetts and employed 1,333 people as of December 2008.

The company recorded revenues of $175.5 million during the financial year (FY) ended December 2008, a decrease of 11.8% over FY2007. The decrease was due to lower revenues from royalties as a result of the sale of its HIV royalty stream and decreases in its revenues from its collaborations. The operating loss of the company was $462.7 million during FY2008, as compared to the operating loss of $419.8 million in FY2007. The net loss of the company was $459.9 million in FY2008, as compared to the net loss of $391.3 million in FY2007.

Key facts

130 Waverly Street , Cambridge , Massachusetts 02139 , USA

Fax : 1 617 444 6680

http://www.vrtx.com

NASDAQ National Market ticker: VRTX

No. employees: 1333

Turnover: 175,500,000 (USD)

Financial year end: December

Summary

  • Key facts
  • Overview
  • Business Description
  • History
  • Key Employees and Biographies
  • Location and Subsidiaries
  • Top Competitors
  • Major Products and Services

SWOT Profiles

This SWOT analysis company profile is the essential source for top level data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Scope of this research

  • Provides all the crucial company information required for business and competitor intelligence needs.
  • Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams.
  • Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Key reasons to purchase this research

  • Support sales activities by understanding your customers' businesses better
  • Qualify prospective partners and suppliers
  • Keep fully up to date on your competitors' business structure, strategy and prospects
  • Obtain the most up to date company information available

Company Profile

Published by
Datamonitor
Published on
25 Aug 2009
Product code
793ECE41-C388-4721-8CF9-1997570D442C
Pages
Please wait...

$125

Multi-user License $313